Watson Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WATSON PHARMS, and what generic and branded alternatives to WATSON PHARMS drugs are available?
WATSON PHARMS has eleven approved drugs.
Drugs and US Patents for Watson Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Pharms Teva | AMOXAPINE | amoxapine | TABLET;ORAL | 072419-001 | Aug 1, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Pharms Teva | ATRACURIUM BESYLATE | atracurium besylate | INJECTABLE;INJECTION | 074945-001 | Jul 28, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Pharms Inc | TESTOSTERONE ENANTHATE | testosterone enanthate | INJECTABLE;INJECTION | 085598-001 | Approved Prior to Jan 1, 1982 | AO | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Pharms Teva | AMOXAPINE | amoxapine | TABLET;ORAL | 072418-001 | Aug 1, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.